Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 American Gastroenterological Association Institute medical position statement on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease.

× No keyword cloud information.

65 in total

Review 1. Optimizing 6-mercaptopurine and azathioprine therapy in the management of inflammatory bowel disease.

Authors: Kara Bradford; David Q Shih
Journal: World J Gastroenterol Date: 2011-10-07 Impact factor: 5.742

Review 2. The role of pharmacogenetics in nonmalignant gastrointestinal diseases.

Authors: Michael Camilleri
Journal: Nat Rev Gastroenterol Hepatol Date: 2012-02-07 Impact factor: 46.802

3. Inflammatory bowel disease in Korea: epidemiological, genomic, clinical, and therapeutic characteristics.

Authors: Eun Soo Kim; Won Ho Kim
Journal: Gut Liver Date: 2010-03-25 Impact factor: 4.519

Review 4. Methotrexate for maintenance of remission in Crohn's disease.

Authors: Vishal Patel; Yongjun Wang; John K MacDonald; John W D McDonald; Nilesh Chande
Journal: Cochrane Database Syst Rev Date: 2014-08-26

5. Long-term outcome of laparoscopic ileocecal resection for Crohn's disease before the era of biologics.

Authors: Andreas D Rink; Ivo R Fischer; Boris Vestweber; Karl-Heinz Vestweber
Journal: Int J Colorectal Dis Date: 2013-07-16 Impact factor: 2.571

6. Predictive role of NUDT15 variants on thiopurine-induced myelotoxicity in Asian inflammatory bowel disease patients.

Authors: Natalia Sutiman; Sylvia Chen; Khoon Lin Ling; Sai Wei Chuah; Wai Fook Leong; Vinayak Nadiger; Madeline Tjai; Chris San Choon Kong; Brian John Schwender; Webber Chan; Hang Hock Shim; Wee Chian Lim; Chiea Chuen Khor; Yin Bun Cheung; Balram Chowbay
Journal: Pharmacogenomics Date: 2017-12-06 Impact factor: 2.533

American Gastroenterological Association Institute medical position statement on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease.

Review 1. Optimizing 6-mercaptopurine and azathioprine therapy in the management of inflammatory bowel disease.

Review 2. The role of pharmacogenetics in nonmalignant gastrointestinal diseases.

3. Inflammatory bowel disease in Korea: epidemiological, genomic, clinical, and therapeutic characteristics.

Review 4. Methotrexate for maintenance of remission in Crohn's disease.

5. Long-term outcome of laparoscopic ileocecal resection for Crohn's disease before the era of biologics.

6. Predictive role of NUDT15 variants on thiopurine-induced myelotoxicity in Asian inflammatory bowel disease patients.

Review 7. Quality improvement in gastroenterology clinical practice.

Review 8. Tools for primary care management of inflammatory bowel disease: do they exist?

9. Therapeutic benefits of budesonide in gastroenterology.

10. Efficacy of 6-mercaptopurine treatment after azathioprine hypersensitivity in inflammatory bowel disease.